Form 4: Zomedica CFO Scott Jordan Acquires 300,000 Shares of Common Stock
SEC Form 4 Filing
Zomedica's Chief Financial Officer, Scott Jordan, recently purchased 300,000 shares of the company's common stock at a price of $0.062 per share.
Summary
- On March 17, 2025, Scott Jordan, the Chief Financial Officer of Zomedica Corp., acquired 300,000 shares of common stock.
- The purchase price was $0.062 per share.
- Following this transaction, Mr. Jordan directly owns 300,000 shares of Zomedica's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While insider buying can be a good sign, the amount is not substantial enough to drastically alter sentiment. It's a moderate positive indicator.
Positives
- The CFO's purchase of a significant number of shares could be interpreted as a positive signal about the company's prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the company's stock is undervalued. However, it's important to consider the size of the purchase relative to the insider's overall holdings and the company's market capitalization.
Stakeholder Impact
- Shareholders may view the CFO's stock purchase as a positive signal.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of transaction: Scott Jordan acquired 300,000 shares of Zomedica common stock. |
| 03/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Zomedica, Scott Jordan, CFO, common stock, share acquisition, Form 4, SEC filing, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.